There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Regulatory approval is a major milestone in the drug development process, but it is not the final chapter in the journey.
Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
The most striking evidence that artificial intelligence can provide profound scientific breakthroughs came with the unveiling of a program called AlphaFold by Google DeepMind. In 2016 researchers at ...
The Chosun Ilbo on MSN
Korean drug industry sees approval surge with two new treatments
Domestic new drugs, which were released at a rate of about one or two per year, have received approval for two new drugs by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results